An Open Label Study of the Effects and Safety of Zanubrutinib in NMOSDs Adult Patients
Clinical trial NCT05356858 · TERMINATED
Trial details
- NCT number
- NCT05356858
- Sponsor
- Xuanwu Hospital, Beijing
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-07
- Primary completion
- 2024-02-24
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.